Viewing Study NCT05705505


Ignite Creation Date: 2025-12-25 @ 3:30 AM
Ignite Modification Date: 2026-07-05 @ 1:38 AM
Study NCT ID: NCT05705505
Status: RECRUITING
Last Update Posted: 2023-12-12
First Post: 2023-01-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Narazaciclib (ON 123300) Plus Letrozole in Endometrial Cancer and Other Gynecologic Malignancies
Sponsor: Traws Pharma, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Endometrioid Endometrial Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Narazaciclib View
None ON 123300 View
None letrozole View